Adverum Biotechnologies, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Adverum Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.96M, a 32.5% decline year-over-year.
  • Adverum Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $15.2M, a 18.5% decline year-over-year.
  • Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.6M, a 12.5% decline from 2022.
  • Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.1M, a 20.3% decline from 2021.
  • Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25.2M, a 23.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.6M -$2.51M -12.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $20.1M -$5.12M -20.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $25.2M +$4.8M +23.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $20.4M +$10.5M +106% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $9.9M -$3.53M -26.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $13.4M +$4.71M +54% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $8.72M -$2.69M -23.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $11.4M -$89K -0.77% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-06
2015 $11.5M +$2.94M +34.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $8.57M +$8.05M +1563% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-04
2013 $515K +$439K +578% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $76K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.